Bafna Pharma

Chennai, India Founded: 1981 • Age: 45 yrs
Provider of formulation services for pharmaceutical industry
Annual revenue $17.1M Latest available
Total funding - Funding intelligence
Employees 406 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Bafna Pharma

Bafna Pharma is a company based in Chennai (India) founded in 1981. The company has 406 employees as of March 31, 2024. Bafna Pharma operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.

  • Headquarter Chennai, India
  • Employees 406 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Bafna Pharmaceuticals Limited
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $17.09 M (USD)
    -4.33
    as on Mar 31, 2025
  • Net Profit
    $485.99 K (USD)
    -43.49
    as on Mar 31, 2025
  • EBITDA
    $1.34 M (USD)
    0.75
    as on Mar 31, 2025
  • Latest Funding Round
  • Investors
  • Employee Count
    406

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Bafna Pharma

Bafna Pharma is a publicly listed company on the NSE with ticker symbol BAFNAPH in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: BAFNAPH · Sector: Health technology · India

Funding Insights of Bafna Pharma

Investments & Acquisitions by Bafna Pharma

Investments

Financial Statements - Bafna Pharma

Bafna Pharma Comparisons

+
Add Comparison
Available on Premium

Competitors of Bafna Pharma

Bafna Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
CDMO focusing on spectrum of dosage forms and therapeutic segments
domain founded_year HQ Location
Company offering a suite of R&D and manufacturing services for small molecules and generics
domain founded_year HQ Location
Pharmaceutical development and manufacturing services are offered contractually.
domain founded_year HQ Location
Contract development and manufacturing organization for proprietary and generic drugs
domain founded_year HQ Location
Cephalosporin APIs and generic formulations are manufactured.
domain founded_year HQ Location
CDMO with a focus on early phase drug product development

Frequently Asked Questions about Bafna Pharma

Bafna Pharma was founded in 1981.

Bafna Pharma is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

As of Mar 31, 2024, the latest employee count at Bafna Pharma is 406.

Annual revenue of Bafna Pharma is $17.09M as on Mar 31, 2025.

Bafna Pharma was established in 1981 in Chennai, India, within the pharmaceutical sector. Manufacturing services focused on formulations are offered, with emphasis on exports to regulated and rest-of-world markets. Domestic operations were initiated in 2011 through the acquisition and launch of Raricap, targeting gynaec and paediatric segments. The company operates from its base in India to serve global and local needs.

Bafna Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Yes, Bafna Pharma is publicly traded on NSE under the ticker symbol BAFNAPH.

The ticker symbol of Bafna Pharma is BAFNAPH on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available